Independent Research advice for BB Biotech
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| July 13, 2012 | Independent Research | BB Biotech | Buy | 80.00 CHF |
Advice details
Frankfurt - Op 13 Jul 2012 herhalen de analisten van Independent Research hun koopadvies voor BB Biotech (ISIN: CH0038389992 / Mnemo: BBZ). Het 12-maands koersdoel wordt opwaarts bijgesteld van 70.0 CHF naar 80.0 CHF.
Back
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2025 ValueSpectrum. All Rights Reserved
Developed and maintained by 